 |
Keck School of Medicine of the University of Southern California | |
| City: Los Angeles | State: CA | |
|
Links:
Commentary:Keck School of Medicine's conflict of interest policies are, on the whole, quite strong. There is a complete ban on gifts and on-site meals. P&T committee members must recuse themselves from any decisions with which they have a conflict of interest. Consulting and speaking relationships require prior approval and fair market compensation; although the policy does not ban participation in speaker’s bureaus outright. Further reducing the marketing impact of samples (by limiting their use or providing equal access to generic samples) would also improve this institution’s overall grade.
This institution's evaluation was last updated: 1/05/2010 |
||
| Gifts & Meals |  |
This institution has a total ban on gifts and on-site meals. |
| Consulting relationships | |
An excellent consulting policy requires prior review and approval of a written agreement before any consulting relationship may commence. Additionally, compensation for consulting services must be at or below fair market value, and is only allowed for legitimate services. |
| Industry-funded speaking relationships |  |
The policy states that faculty may engage in industry-sponsored speaking relationships as long as industry does not have any influence on presentation content and it complies with ACCME, ACPE, or ADA standards, as appropriate, whether CME credit is issued or not. Additionally, all speaking engagements must receive prior approval, a commendable policy. Were long-term promotional speaking relationships, such as speaker’s bureaus, to be completely prohibited (rather than strongly discouraged), this otherwise very strong policy would score a 3 in this domain. |
| Disclosure | |
All consulting relationships, speaking relationships, service on advisory committees (and any other service to industry for payment) must be disclosed to the institution for prior approval, and to students, residents and fellows when the relationship is related to a product discussed in an educational setting. For a three in this domain, public disclosure or disclosure to patients could be included. |
| Pharmaceutical samples | |
Pharmaceutical samples must be dispensed from a central location, and may not be accepted directly by physicians from industry sales representatives. |
| Purchasing & Formularies | |
This institution takes a strong stance in the area of purchasing/formularies, by requiring committee members to disclose any relationships with industry and recuse themselves from any decisions pertaining to these relationships. |
| Industry Sales Representatives | |
Industry sales representatives may only meet with faculty by appointment and in non-patient care areas. |
| On-campus Education | |
ACCME standards are used as a benchmark for on-site educational activities. Additionally, the policy specifies that monies coming from industry sales and marketing departments should only be accepted in special circumstances. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
Conference attendees must not accept any reimbursement from industry for travel to off-site events. |
| Industry Support for Scholarships & Funds for Trainees | |
Recipients of trainee funds or scholarships must be selected by the institution. All funds must be processed through the institution and must not be given to the recipient directly from industry. |
| Medical school curriculum | |
This institution provides a senior seminar on policies governing industry relationships with medical professionals. Students must read materials on industry relationships and the potential influence of those relationships, and understand the perspectives of various university stakeholders in the formation of an industry-interaction policy. Other curriculum covers direct to consumer advertising and drug development. |
| Do the policies specify an oversight mechanism? |  |
No oversight or responsible party specified in this policy. |
| Are there explicit sanctions for noncompliance? |  |
Sanctions for noncompliance are referenced. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
